Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P…
Biotechnology
US, Bellaire [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Bio-Path Holdings, Inc. has no acquisition track records yet.
M&A Deals · History
Bio-Path Holdings, Inc. has no acquisition track records yet.